Cervical cancer prevention for women living with HIV in East Africa
Official title: KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
Funded at Kenya Medical Research Institute (Kemri) · NIH-11413651 · Data updated 2026-11-12
A networked study in Kenya aims to prevent cervical cancer among women with HIV by testing screen-and-treat strategies at HIV clinics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kenya Medical Research Institute (Kemri) NIH-funded |
| Lab location | 1 site (Nairobi City, Kenya) |
| Project start | September 19, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $40,762 |
| NIH project number | 5UG1CA285132-04 |
| Project ID | NIH-11413651 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women living with HIV who receive care at the participating clinics in Kiambu County, Kenya, and who are eligible for cervical cancer prevention interventions.
✕Less likely to help
Individuals not living with HIV or not engaged in the participating clinics may not directly benefit from this study.
What this research studies
This project brings together HIV and cervical cancer experts to implement prevention studies at three public HIV clinics in Kiambu County, Kenya. It will adapt and run HIV/cervical cancer prevention approaches within real-world care settings, leveraging existing programs and staff. The effort seeks to reduce cervical cancer deaths by applying tested prevention methods among women living with HIV in low-resource environments.
Why it matters
Potential benefit: If successful, it could lower cervical cancer deaths among women living with HIV by improving early detection and prevention in routine care settings.
How similar studies have gone: Past implementation efforts in similar low-resource settings suggest that screen-and-treat approaches can work when integrated into HIV care.
Where this research is happening
-
Kenya Medical Research Institute (Kemri)
Nairobi City, Kenya Active
Researchers
- Principal investigator: Mugo, Nelly Rwamba — Kenya Medical Research Institute (Kemri)
- Study coordinator: Mugo, Nelly Rwamba
Related research
Other NIH-funded projects on the same topics.
-
Community and digital tools to reduce HPV and cervical cancer burden
A nurse or health team will test a community-based, digital strategy to help girls and young women, especially in rural areas, get HPV vaccination and cervical cancer prevention services.
-
Community and digital tools to reduce HPV and cervical cancer in women with HIV
A community- and digital-technology program aims to help girls and young women, including those with HIV, get more HPV vaccination and cervical cancer prevention services.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.